BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 11600574)

  • 1. Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms.
    McTernan CL; Draper N; Nicholson H; Chalder SM; Driver P; Hewison M; Kilby MD; Stewart PM
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4979-83. PubMed ID: 11600574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery.
    Dy J; Guan H; Sampath-Kumar R; Richardson BS; Yang K
    Placenta; 2008 Feb; 29(2):193-200. PubMed ID: 18061258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction.
    Shams M; Kilby MD; Somerset DA; Howie AJ; Gupta A; Wood PJ; Afnan M; Stewart PM
    Hum Reprod; 1998 Apr; 13(4):799-804. PubMed ID: 9619527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression and activity of 11beta-hydroxysteroid dehydrogenase in human placenta and fetal membranes from pregnancies with intrauterine growth restriction.
    Wächter R; Masarik L; Bürzle M; Mallik A; von Mandach U
    Fetal Diagn Ther; 2009; 25(3):328-35. PubMed ID: 19776596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased gene expression of 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase in human placenta of patients with preeclampsia.
    Schoof E; Girstl M; Frobenius W; Kirschbaum M; Dörr HG; Rascher W; Dötsch J
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1313-7. PubMed ID: 11238526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression patterns of the 11β-hydroxysteroid dehydrogenase 2 enzyme in human placenta from intrauterine growth restriction: the role of impaired feto-maternal glucocorticoid metabolism.
    Börzsönyi B; Demendi C; Pajor A; Rigó J; Marosi K; Agota A; Nagy ZB; Joó JG
    Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):12-7. PubMed ID: 22239940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11beta-hydroxysteroid dehydrogenase type 2 is the predominant isozyme in the guinea pig placenta: decreases in messenger ribonucleic acid and activity at term.
    Sampath-Kumar R; Matthews SG; Yang K
    Biol Reprod; 1998 Dec; 59(6):1378-84. PubMed ID: 9828181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of placental 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase mRNA expression during human gestation.
    Schoof E; Girstl M; Frobenius W; Kirschbaum M; Repp R; Knerr I; Rascher W; Dötsch J
    Eur J Endocrinol; 2001 Aug; 145(2):187-92. PubMed ID: 11454515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma.
    Murphy VE; Zakar T; Smith R; Giles WB; Gibson PG; Clifton VL
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1660-8. PubMed ID: 11932298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of restriction of placental and fetal growth on expression of 11beta-hydroxysteroid dehydrogenase type 1 and type 2 messenger ribonucleic acid in the liver, kidney, and adrenal of the sheep fetus.
    McMillen IC; Warnes KE; Adams MB; Robinson JS; Owens JA; Coulter CL
    Endocrinology; 2000 Feb; 141(2):539-43. PubMed ID: 10650933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia blocks 11beta-hydroxysteroid dehydrogenase type 2 induction in human trophoblast cells during differentiation by a time-dependent mechanism that involves both translation and transcription.
    Homan A; Guan H; Hardy DB; Gratton RJ; Yang K
    Placenta; 2006 Aug; 27(8):832-40. PubMed ID: 16271275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11Beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human placenta.
    Hirasawa G; Takeyama J; Sasano H; Fukushima K; Suzuki T; Muramatu Y; Darnel AD; Kaneko C; Hiwatashi N; Toyota T; Nagura H; Krozowski ZS
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1306-9. PubMed ID: 10720080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pro-inflammatory cytokines on expression and activity of 11beta-hydroxysteroid dehydrogenase type 2 in cultured human term placental trophoblast and human choriocarcinoma JEG-3 cells.
    Chisaka H; Johnstone JF; Premyslova M; Manduch Z; Challis JR
    J Soc Gynecol Investig; 2005 Jul; 12(5):303-9. PubMed ID: 15979541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone, estrogen, and the cyclic adenosine 5'-monophosphate pathway in cultured human placental and chorionic trophoblasts.
    Sun K; Yang K; Challis JR
    Biol Reprod; 1998 Jun; 58(6):1379-84. PubMed ID: 9623596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming.
    Seckl JR; Cleasby M; Nyirenda MJ
    Kidney Int; 2000 Apr; 57(4):1412-7. PubMed ID: 10760076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor delta suppresses 11beta-hydroxysteroid dehydrogenase type 2 gene expression in human placental trophoblast cells.
    Julan L; Guan H; van Beek JP; Yang K
    Endocrinology; 2005 Mar; 146(3):1482-90. PubMed ID: 15591138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental 11 beta-hydroxysteroid dehydrogenase-2 and fetal cortisol/cortisone shuttle in small preterm infants.
    Kajantie E; Dunkel L; Turpeinen U; Stenman UH; Wood PJ; Nuutila M; Andersson S
    J Clin Endocrinol Metab; 2003 Jan; 88(1):493-500. PubMed ID: 12519895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foetal and placental 11β-HSD2: a hub for developmental programming.
    Cottrell EC; Seckl JR; Holmes MC; Wyrwoll CS
    Acta Physiol (Oxf); 2014 Feb; 210(2):288-95. PubMed ID: 24330050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease.
    Seckl JR
    Steroids; 1997 Jan; 62(1):89-94. PubMed ID: 9029721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 and 2 in human placentas of term pregnancies according to birth weight and gender.
    Mericq V; Medina P; Kakarieka E; Márquez L; Johnson MC; Iñiguez G
    Eur J Endocrinol; 2009 Sep; 161(3):419-25. PubMed ID: 19542242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.